Net Cash Provided by (Used in) Financing Activities of BIODESIX INC from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIODESIX INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • BIODESIX INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $97,000, a 88% decline year-over-year.
  • BIODESIX INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $16,417,000, a 68% decline from 2024.
  • BIODESIX INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $52,050,000, a 79% increase from 2023.
  • BIODESIX INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $29,129,000, a 51% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BIODESIX INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $16,417,000 -$35,633,000 -68% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $52,050,000 +$22,921,000 +79% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $29,129,000 -$29,753,000 -51% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $58,882,000 +$57,620,000 +4566% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2024 2023 FY
2021 $1,262,000 -$79,869,000 -98% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $81,131,000 +$58,159,000 +253% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022 2021 FY
2019 $22,972,000 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY

BIODESIX INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $97,000 -$694,000 -88% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $791,000 +$3,212,000 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $2,421,000 +$413,000 +15% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $2,834,000 -$7,785,000 -157% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $4,951,000 -$1,469,000 -23% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q1 2020 $6,420,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.